202 related articles for article (PubMed ID: 36547459)
1. Excessive Supraventricular Ectopic Activity and the Risk of Atrial Fibrillation and Stroke: A Systematic Review and Meta-Analysis.
Yang M; Lin Y; Cheng H; Zheng D; Tan S; Zhu L; Li Z; Wang X; Yang J
J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547459
[TBL] [Abstract][Full Text] [Related]
2. Excessive Supraventricular Ectopic Activity and Adverse Cardiovascular Outcomes: a Systematic Review and Meta-analysis.
Meng L; Tsiaousis G; He J; Tse G; Antoniadis AP; Korantzopoulos P; Letsas KP; Baranchuk A; Qi W; Zhang Z; Liu E; Xu G; Xia Y; Li G; Roever L; Lip GY; Fragakis N; Liu T
Curr Atheroscler Rep; 2020 May; 22(4):14. PubMed ID: 32440839
[TBL] [Abstract][Full Text] [Related]
3. Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.
Larsen BS; Kumarathurai P; Falkenberg J; Nielsen OW; Sajadieh A
J Am Coll Cardiol; 2015 Jul; 66(3):232-241. PubMed ID: 26184616
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure-Results from the DANISH trial.
Boas R; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Dixen U
Am Heart J; 2021 Feb; 232():61-70. PubMed ID: 33144085
[TBL] [Abstract][Full Text] [Related]
5. Excessive supraventricular ectopic activity and future onset of atrial fibrillation in patients with cryptogenic stroke.
Gogos C; Zarvalis E; Pantelidis P; Davora F; Karakanas A; Pitetzis D; Stamatiadis N; Moschovidis V; Konstantinidou M; Oikonomou E; Deretzi G; Rudolf J; Styliadis I
J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106820. PubMed ID: 36323164
[TBL] [Abstract][Full Text] [Related]
6. Excessive supraventricular ectopic activity and risk of incident atrial fibrillation in a consecutive population referred to ambulatory cardiac monitoring.
Larsen BS; Aplin M; Nielsen OW; Dominguez Vall-Lamora MH; Høst NB; Kristiansen OP; Rasmusen HK; Davidsen U; Karlsen FM; Højberg S; Sajadieh A
Heart Rhythm O2; 2021 Jun; 2(3):231-238. PubMed ID: 34337573
[TBL] [Abstract][Full Text] [Related]
7. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke.
Binici Z; Intzilakis T; Nielsen OW; Køber L; Sajadieh A
Circulation; 2010 May; 121(17):1904-11. PubMed ID: 20404258
[TBL] [Abstract][Full Text] [Related]
8. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
[TBL] [Abstract][Full Text] [Related]
9. Prolonged Cardiac Monitoring to Detect Atrial Fibrillation after Cryptogenic Stroke or Transient Ischemic Attack: A Meta-Analysis of Randomized Controlled Trials.
Dahal K; Chapagain B; Maharjan R; Farah HW; Nazeer A; Lootens RJ; Rosenfeld A
Ann Noninvasive Electrocardiol; 2016 Jul; 21(4):382-8. PubMed ID: 26524619
[TBL] [Abstract][Full Text] [Related]
10. Premature atrial complexes can predict atrial fibrillation in ischemic stroke patients: A systematic review and meta-analysis.
Tao Y; Xu J; Gong X; Sun J; Yang D
Pacing Clin Electrophysiol; 2021 Sep; 44(9):1599-1606. PubMed ID: 34170567
[TBL] [Abstract][Full Text] [Related]
11. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
[TBL] [Abstract][Full Text] [Related]
12. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
[TBL] [Abstract][Full Text] [Related]
13. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
[TBL] [Abstract][Full Text] [Related]
14. Frequent premature atrial contractions are associated with atrial fibrillation, brain ischaemia, and mortality: a systematic review and meta-analysis.
Himmelreich JCL; Lucassen WAM; Heugen M; Bossuyt PMM; Tan HL; Harskamp RE; van Etten-Jamaludin FS; van Weert HCPM
Europace; 2019 May; 21(5):698-707. PubMed ID: 30508087
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four
Liu F; Wang Y; Luo J; Huang L; Zhu W; Yin K; Xue Z
Front Cardiovasc Med; 2022; 9():841341. PubMed ID: 35310968
[TBL] [Abstract][Full Text] [Related]
16. Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies.
Guo Z; Ding X; Ye Z; Chen W; Chen Y
Clin Cardiol; 2021 Jul; 44(7):917-924. PubMed ID: 34013988
[TBL] [Abstract][Full Text] [Related]
17. Excessive supraventricular activity and risk of atrial fibrillation in patients with cryptogenic ischaemic stroke.
Maretta M; Šimurda M; Leško N; Gbúr M; Škorvánek M; Mišíková S; Gdovinová Z
Neurol Neurochir Pol; 2022; 56(1):75-80. PubMed ID: 35050495
[TBL] [Abstract][Full Text] [Related]
18. Signs of left atrial disease and 10-year risk of atrial fibrillation.
Uhe T; Stegmann T; Langhammer R; Dagres N; Laufs U; Wachter R
PLoS One; 2022; 17(4):e0266848. PubMed ID: 35452471
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
20. [Causes of death and influencing factors of atrial fibrillation patients undergoing anticoagulation therapy].
Hua C; Jiang C; He L; Jia ZX; Lyu WH; Tang RB; Sang CH; Long DY; Dong JZ; Ma CS; Du X
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):353-359. PubMed ID: 33874685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
